Distribution pattern of basal cells detected by cytokeratin 34 beta E12 in primary prostatic duct adenocarcinoma

American Journal of Surgical Pathology

Volumn 21, Issue 4, 1997, Pages 435-440

  Samaratunga, Hemamali ^a   Singh, Mahendra ^b  

^a ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

^b Queensland Government   (Australia)

Author keywords

Cytokeratin 34 beta E12; Endometrioid carcinoma; Immunohistochemistry; Prostatic duct adenocarcinoma

Indexed keywords

ACID PHOSPHATASE PROSTATE ISOENZYME; CYTOKERATIN; PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; BASAL CELL; CANCER CLASSIFICATION; CANCER CYTODIAGNOSIS; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; PROSTATE ADENOCARCINOMA; PROTEIN LOCALIZATION;

EID: 0030974866     PISSN: 01475185     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000478-199704000-00009     Document Type: Article

References (19)

1. Bates HR Jr, Thornton JL. Adenocarcinoma of primary prostatic ducts and utricle. Arch Pathol Lab Med 1973;96:207.
2. Bostwick DG, Kindrachuk RW, Rouse RV. Prostatic adenocarcinoma with endometrioid features. Am J Surg Pathol 1985;9:595-609.
3. Brawer MK. Prostatic intraepithelial neoplasia: a premalignant lesion. Hum Pathol 1992;23:242-8.
4. Carney JA, Kelalis PP. Endometrial carcinoma of the prostatic utricle. Am J Clin Pathol 1973;60:565-9.
5. Drake WM, Burrows S. Papillary carcinoma of prostatic ducts. Urology 1974;3:621-3.
6. Dube VE, Farrow GM, Green LF. Prostatic adenocarcinoma of ductal origin. Cancer 1973;32:402-9.
7. Dube VE, Joyce GT, Kennedy E. Papillary primary duct adenocarcinoma of the prostate. J Urol 1972;107:825-6.
8. Epstein JI. Prostatic intraepithelial neoplasia. Adv Anat Pathol 1994;1:123-4.
9. Epstein JI, Woodruff JM. Adenocarcinoma of the prostate with endometrioid features. Cancer 1986;57:111-9.
10. Hardemann SW, Soloway MS. Transitional cell carcinoma of the prostate: diagnosis, management and staging. World J Urol 1988;6:170.
11. Hedrick L, Epstein JI. Use of keratin 903 as an adjunct in the diagnosis of prostate carcinoma. Am J Surg Pathol 1989; 13:389-96.
12. Lee SG. Endometrioid adenocarcinoma of the prostate. A clinico pathologic and immunohistochemical study. J Surg Oncol 1994;55:235-8.
13. Melicow MM, Pachter MR. Endometrial carcinoma of prostatic utricle (uterus masculinus). Cancer 1967;20:1715-21.
14. Melicow MM, Tannenbaum M. Endometrial carcinoma of uterus masculinus (prostatic utricle). Report of six cases. J Urol 1971;106:892-902.
15. McNeal JE, Bostrick DG. Intraductal dysplasia. A premalignant lesion of the prostate. Hum Pathol 1986;17:64-71.
16. Ro JY, Ayala AG, Wishnow KI, Ordonez NG. Prostatic duct adenocarcinoma with endometrioid features: immunohistochemical and electron microscopic study. Semin Diagn Pathol 1988;5:301-11.
17. Schaafsma HE, Ramaechers FC, Van Muijen GN, et al. Cytokeratin expression patterns in metastatic transitional cell carcinoma of the urinary tract. An immunohistochemical study comparing local tumour and autologous metastases. Am J Pathol 1991;139:1389-1400.
18. Totten RS, Heinemann MW, Hudson PB, Sproul EF, Stout AP. Microscopic differential diagnosis of latent carcinoma of prostate. Arch Pathol 1953;55:131-41.
19. Vale JA, Patel A, Ball AJ, Hendry WF, Chappell ME, Fisher C. Endometrioid carcinoma of prostate. A misnomer? J R Soc Med 1992;85:394-6.